Arrowhead Pharmaceuticals Inc (ARWR)

R&D to Revenue

263.41%

Quarterly · Period ending:

ARWR logo

ARWR R&D to Revenue

Latest reported263.41%
ARWR Quarterly R&D/Revenue (0.00% → 263.41%)
High-resolution chart · PNG

ARWR r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Arrowhead Pharmaceuticals Inc R&D to Revenue — Quarterly
Period endingR&D to Revenue
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.